Article info

Download PDFPDF
Extended report
A 24-month open-label study of canakinumab in neonatal-onset multisystem inflammatory disease

Authors

  1. Correspondence to Dr Raphaela Goldbach-Mansky, Translational Autoinflammatory Section, NIH/NIAMS, Building 10 Room 6D47-B, 10 Center Dr., Bethesda, MD 20892, USA; goldbacr{at}mail.nih.gov
View Full Text

Citation

Sibley CH, Chioato A, Felix S, et al
A 24-month open-label study of canakinumab in neonatal-onset multisystem inflammatory disease

Publication history

  • Received November 11, 2013
  • Revised March 21, 2014
  • Accepted April 13, 2014
  • First published June 6, 2014.
Online issue publication 
August 10, 2015

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.